Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178670-26-000047
Filing Date
2026-06-03
Accepted
2026-06-03 16:23:40
Documents
1
Period of Report
2026-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3839
  Complete submission text file 0001178670-26-000047.txt   5418
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address
Cravatt Benjamin (Reporting) CIK: 0001819573 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 261060995